Journal
AMB EXPRESS
Volume 4, Issue -, Pages -Publisher
SPRINGER
DOI: 10.1186/s13568-014-0057-4
Keywords
Chlamydomonas; Chloroplast transformation; Recombinant therapeutic proteins
Categories
Funding
- Instituto Politecnico Nacional [SIP-20121514]
- ICYT-DF [PIUTE 10-74, PICSA 10-174]
- PIFI-IPN
- National Council of Science and Technology (CONACYT)
- EDI-IPN
- COFAA-IPN
Ask authors/readers for more resources
Chloroplast transformation in the photosynthetic alga Chlamydomonas reinhardtii has been used to explore the potential to use it as an inexpensive and easily scalable system for the production of therapeutic recombinant proteins. Diverse proteins, such as bacterial and viral antigens, antibodies and, immunotoxins have been successfully expressed in the chloroplast using endogenous and chimeric promoter sequences. In some cases, proteins have accumulated to high level, demonstrating that this technology could compete with current production platforms. This review focuses on the works that have engineered the chloroplast of C. reinhardtii with the aim of producing recombinant proteins intended for therapeutical use in humans or animals.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available